The role of PSMA PET/CT to predict upgrading in patients undergoing radical prostatectomy for ISUP grade group 1 prostate cancer.
Baris EsenHulya SeymenBengi GursesAyse ArmutluErsin KoseogluKayhan TarimDilek Ertoy BaydarAhmet Furkan SarikayaAbdullah Erdem CandaDerya BalbayYakup KordanDerya TilkiTarik EsenMehmet Onur DemirkolPublished in: The Prostate (2023)
High prostatic PSMA uptake was found to be a very reliable predictor of pathological upgrading, but low PSMA uptake cannot exclude pathological upgrading. Intraprostatic PSMA uptake along with previously known mpMRI and biopsy-related parameters should be considered when making a treatment decision in patients with GG1 PCa at prostate biopsy.